Chemotherapy before surgery can improve survival rates in pancreatic cancer patients

Close Up Scientist using microscope in laboratory room while making medical testing and research

Treating pancreatic cancer patients with chemotherapy before surgery significantly improved 1-year survival rates compared to immediate surgery, a randomized clinical trial has found.

To stop spread of cancer, researchers target two signaling switches that trigger new blood vessel growth

Previous article

Immunogenicity of SARS-CoV-2 antibody response in immune naïve children and adults

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations